CBPH法检测精液中SARS-CoV-2的最高灵敏度研究
本研究评估了qRT-PCR、OSN-qRT-PCR、cd-PCR和CBPH四种核酸检测方法对SARS-CoV-2的临床性能。CBPH的灵敏度和特异性及AUC显著高于其他三种方法,并在12例康复患者中检出3例精液样本存在SARS-CoV-2基因组片段,但配对尿液样本未检出。现有SARS-CoV-2基因组片段随时间被代谢。
要点
- CBPH法检测SARS-CoV-2的灵敏度和特异性及AUC显著高于qRT-PCR、OSN-qRT-PCR和cd-PCR。
- 12例康复患者中,仅CBPH在3例精液样本中检出SARS-CoV-2基因组片段,配对尿液样本未检出。
- 精液中检出的SARS-CoV-2片段随时间代谢,出院后至少3个月内男性伴侣间不太可能发生性传播。
核心结论
- CBPH在检测SARS-CoV-2方面具有最高的诊断性能,有助于确定低病毒载量灰区样本的临界值。
- 尽管CBPH证实精液中存在SARS-CoV-2片段,但COVID-19在出院后至少3个月内不太可能通过男性伴侣性传播。
研究设计与样本
- 使用236例实验室确诊COVID-19病例的临床样本评估qRT-PCR、OSN-qRT-PCR、cd-PCR和CBPH对SARS-CoV-2的检测性能。
- 使用24对精液、血液、咽拭子和尿液样本,平行检测12例康复患者中SARS-CoV-2的存在。
主要发现
- CBPH的灵敏度和特异性及AUC显著高于其他三种方法。
- qRT-PCR、OSN-qRT-PCR和cd-PCR在12例患者的咽拭子、血液、尿液和精液样本中均未检出SARS-CoV-2 RNA。
- CBPH在3例患者的精液样本中检出SARS-CoV-2基因组片段,但配对尿液样本未检出。
- 现有的SARS-CoV-2基因组片段随时间被代谢。
关键数值与推荐
- CBPH的灵敏度和特异性及AUC显著高于qRT-PCR、OSN-qRT-PCR和cd-PCR。
- 12例康复患者中,CBPH检出3例精液样本存在SARS-CoV-2基因组片段,配对尿液样本未检出。
临床怎么用
- CBPH可用于低病毒载量临床样本中SARS-CoV-2的检测,提高灰区样本的检出率。
- 对于COVID-19康复患者,可采用CBPH监测精液中SARS-CoV-2的清除情况,以评估性传播风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Great concerns have been raised on SARS-CoV-2 impact on men's andrological well-being, and many studies have attempted to determine whether SARS-CoV-2 is present in the semen and till now the data are unclear and somehow ambiguous. However, these studies used quantitative real-time (qRT) PCR, which is not sufficiently sensitive to detect nucleic acids in clinical samples with a low viral load. METHODS: The clinical performance of various nucleic acid detection methods (qRT-PCR, OSN-qRT-PCR, cd-PCR, and CBPH) was assessed for SARS-CoV-2 using 236 clinical samples from laboratory-confirmed COVID-19 cases. Then, the presence of SARS-CoV-2 in the semen of 12 recovering patients was investigated using qRT-PCR, OSN-qRT-PCR, cd-PCR, and CBPH in parallel using 24 paired semen, blood, throat swab, and urine samples. RESULTS: The sensitivity and specificity along with AUC of CBPH was markedly higher than the other 3methods. Although qRT-PCR, OSN-qRT-PCR and cdPCR detected no SARS-CoV-2 RNA in throat swab, blood, urine, and semen samples of the 12 patients, CBPH detected the presence of SARS-CoV-2 genome fragments in semen samples, but not in paired urine samples, of 3 of 12 patients. The existing SARS-CoV-2 genome fragments were metabolized over time. CONCLUSIONS: Both OSN-qRT-PCR and cdPCR had better performance than qRT-PCR, and CBPH had the highest diagnostic performance in detecting SARS-CoV-2, which contributed the most improvement to the determination of the critical value in gray area samples with low vrial load, which then provides a rational screening strategy for studying the clearance of coronavirus in the semen over time in patients recovering from COVID-19. Although the presence of SARS-CoV-2 fragments in the semen was demonstrated by CBPH, COVID-19 is unlikely to be sexually transmitted from male partners for at least 3 months after hospital discharge.
引用
- Zhou SF, Huang C, Li SK, et al. CBPH assay for the highest sensitive detection of SARS-COV-2 in the semen. Clin Chim Acta. 2023. PMID: 37271272. doi:10.1016/j.cca.2023.117415
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。